SCHEMBL20071085

SCHEMBL20071085

COc1ccc(CN2CCN(C)C(C)C2)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV6 Q9H1D0 1/20 0.51
HRH3 Q9Y5N1 1/20 0.44
RET P07949 2/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
JAK3 P52333 1/20 0.41
HRH2 P25021 1/20 0.40
CACNA1G O43497 1/20 0.40
CACNA1H O95180 1/20 0.40
CACNA1I Q9P0X4 1/20 0.40
PDE9A O76083 2/20 0.39
PDE1C Q14123 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PIK3CG P48736 1/20 0.39
PRKAB2 O43741 1/20 0.39
PRKAG1 P54619 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22030570 0.86 TRPV6 (0.50) TRPV6HRH3RETJAK2JAK1
SCHEMBL20071090 0.84 TRPV6 (0.48) TRPV6HRH3RETJAK2JAK1
SCHEMBL20153146 0.84 TRPV6 (0.48) TRPV6HRH3RETJAK2JAK1
SCHEMBL22877040 0.82 CHRNB1 (0.43) HRH3ALDH1A1SMN1; SMN2
SCHEMBL23589171 0.81 TRPV6 (0.53) TRPV6HRH3JAK2JAK1JAK3
SCHEMBL20203570 0.81 CDK1 (0.39) HRH3ALDH1A1SMN1; SMN2
SCHEMBL20203575 0.81 CDK1 (0.39) HRH3ALDH1A1SMN1; SMN2
SCHEMBL18713082 0.80 TRPV6 (0.57) TRPV6HRH3JAK2JAK1JAK3
SCHEMBL22876990 0.80 HRH3 (0.48) HRH3ALDH1A1SMN1; SMN2
SCHEMBL22876975 0.79 IDH1 (0.40) HRH3ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753939-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS Array Biopharma Inc. (US) 2020-12-23 EP disclosed
US-20180134702-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed
WO-2018071447-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134702-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF TRPV6 4180/4885HRH3 1148/4885RET 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.